Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Eclipse Surgical Secures $20 Million Equity Commitment
Aug 2000
SUNNYVALE, Calif., Aug. 18 -- Eclipse Surgical Technologies Inc., a medical device company specializing in transmyocardial revascularization, has received a $20-million commitment in common stock equity financing from Acqua Wellington North American Equities Fund Ltd. The investment will be distributed over the next 15 months and is subject to change depending on Eclipse's stock price. Eclipse will control when and how much stock is sold.
Eclipse is in a strong leadership position in the emerging TMR market, said Alan L. Kaganov, CEO of Eclipse Surgical. This facility provides the flexibility to raise capital over the next 15 months, thereby keeping Eclipse well capitalized to achieve our operating goals, said Kaganov.

News & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.